These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35783838)

  • 1. Plasma Exosome miRNAs Profile in Patients With ST-Segment Elevation Myocardial Infarction.
    Guan R; Zeng K; Zhang B; Gao M; Li J; Jiang H; Liu Y; Qiang Y; Liu Z; Li J; Yang Y
    Front Cardiovasc Med; 2022; 9():848812. PubMed ID: 35783838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal miR-152-5p and miR-3681-5p function as potential biomarkers for ST-segment elevation myocardial infarction.
    Chen X; Huang F; Liu Y; Liu S; Tan G
    Clinics (Sao Paulo); 2022; 77():100038. PubMed ID: 35751950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Next-Generation Sequencing of Plasma Exosome-Derived microRNAs and Target Gene Analysis with a Microarray Database of Thermally Injured Skins: Identification of Blood-to-Tissue Interactions at Early Burn Stage.
    Li SJ; Cai ZW; Yang HF; Tang XD; Fang X; Qiu L; Wang F; Chen XL
    J Inflamm Res; 2021; 14():6783-6798. PubMed ID: 34916825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-146a-5p, miR-223-3p and miR-142-3p as Potential Predictors of Major Adverse Cardiac Events in Young Patients with Acute ST Elevation Myocardial Infarction-Added Value over Left Ventricular Myocardial Work Indices.
    Scărlătescu AI; Barbălată T; Sima AV; Stancu C; Niculescu LȘ; Micheu MM
    Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of Serum miR-23a, miR-30d, and miR-146a Biomarkers in ST-Elevation Myocardial Infarction.
    Bukauskas T; Mickus R; Cereskevicius D; Macas A
    Med Sci Monit; 2019 May; 25():3925-3932. PubMed ID: 31130720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial DNA Together with miR-142-3p in Plasma Can Predict Unfavorable Outcomes in Patients after Acute Myocardial Infarction.
    Barbalata T; Scarlatescu AI; Sanda GM; Toma L; Stancu CS; Dorobantu M; Micheu MM; Sima AV; Niculescu LS
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Cell and Plasma microRNA Profiles Differ between Non-ST-Segment and ST-Segment-Elevation Myocardial Infarction.
    Ward JA; Esa N; Pidikiti R; Freedman JE; Keaney JF; Tanriverdi K; Vitseva O; Ambros V; Lee R; McManus DD
    Fam Med Med Sci Res; 2013 Oct; 2(2):108. PubMed ID: 24432306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the expression level of miR-17-3p, miR-101-3p, miR-335-3p, and miR-296-3p in the peripheral blood of patients with acute myocardial infarction.
    Bakhshi A; Khani M; Alipour Parsa S; Khaheshi I; Namazi MH; Mazouri A; Bidram P; Safi M; Vakili H; Eslami V; Saadat H; Heidari L; Sohrabifar N
    Mol Cell Biochem; 2024 Apr; 479(4):859-868. PubMed ID: 37222878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-941 as a promising biomarker for acute coronary syndrome.
    Bai R; Yang Q; Xi R; Li L; Shi D; Chen K
    BMC Cardiovasc Disord; 2017 Aug; 17(1):227. PubMed ID: 28830367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarction.
    Jaguszewski M; Osipova J; Ghadri JR; Napp LC; Widera C; Franke J; Fijalkowski M; Nowak R; Fijalkowska M; Volkmann I; Katus HA; Wollert KC; Bauersachs J; Erne P; Lüscher TF; Thum T; Templin C
    Eur Heart J; 2014 Apr; 35(15):999-1006. PubMed ID: 24046434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic approach to identify serum microRNAs as potential biomarkers for acute myocardial infarction.
    Hsu A; Chen SJ; Chang YS; Chen HC; Chu PH
    Biomed Res Int; 2014; 2014():418628. PubMed ID: 24900964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating miR-1 as a potential predictor of left ventricular remodeling following acute ST-segment myocardial infarction using cardiac magnetic resonance.
    Ma Q; Ma Y; Wang X; Li S; Yu T; Duan W; Wu J; Wen Z; Jiao Y; Sun Z; Hou Y
    Quant Imaging Med Surg; 2020 Jul; 10(7):1490-1503. PubMed ID: 32676367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma hsa-miR-22-3p Might Serve as an Early Predictor of Ventricular Function Recovery after ST-Elevation Acute Myocardial Infarction.
    Maries L; Moatar AI; Chis AR; Marian C; Luca CT; Sirbu IO; Gaiță D
    Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Exosome-Enriched Extracellular Vesicles From Lactating Mothers With Type 1 Diabetes Contain Aberrant Levels of miRNAs During the Postpartum Period.
    Frørup C; Mirza AH; Yarani R; Nielsen LB; Mathiesen ER; Damm P; Svare J; Engelbrekt C; Størling J; Johannesen J; Mortensen HB; Pociot F; Kaur S
    Front Immunol; 2021; 12():744509. PubMed ID: 34691048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes.
    Ntoumou E; Tzetis M; Braoudaki M; Lambrou G; Poulou M; Malizos K; Stefanou N; Anastasopoulou L; Tsezou A
    Clin Epigenetics; 2017; 9():127. PubMed ID: 29255496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling and validation of circulating microRNAs for cardiovascular events in patients presenting with ST-segment elevation myocardial infarction.
    Jakob P; Kacprowski T; Briand-Schumacher S; Heg D; Klingenberg R; Stähli BE; Jaguszewski M; Rodondi N; Nanchen D; Räber L; Vogt P; Mach F; Windecker S; Völker U; Matter CM; Lüscher TF; Landmesser U
    Eur Heart J; 2017 Feb; 38(7):511-515. PubMed ID: 28011706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating miR-221-3p as a novel marker for early prediction of acute myocardial infarction.
    Coskunpinar E; Cakmak HA; Kalkan AK; Tiryakioglu NO; Erturk M; Ongen Z
    Gene; 2016 Oct; 591(1):90-96. PubMed ID: 27374153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA Derived from Circulating Exosomes as Noninvasive Biomarkers for Diagnosing Renal Cell Carcinoma.
    Xiao CT; Lai WJ; Zhu WA; Wang H
    Onco Targets Ther; 2020; 13():10765-10774. PubMed ID: 33122915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Variables Influence the Ability of miR-101, miR-150, and miR-21 to Predict Ventricular Remodeling after ST-Elevation Myocardial Infarction.
    Maries L; Moatar AI; Sala-Cirtog M; Sima L; Anghel A; Marian C; Chis AR; Sirbu IO
    Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating MicroRNAs as Novel Potential Biomarkers for Left Ventricular Remodeling in Postinfarction Heart Failure.
    Gao G; Chen W; Liu M; Yan X; Yang P
    Dis Markers; 2019; 2019():5093803. PubMed ID: 31885737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.